Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Maurice Winn who wrote (1162)	1/27/1998 5:36:00 AM
From: EZLibra	Read Replies (1) \| Respond to of 3702

Maurice, that was interesting. Ginsberg has been a confirmed Idec bull, having joined Piper from Vector which was one of the original Idec plugs. He still has a buy on IDPH but seems to be readying for a change. He has looked at TCLN and, I am told, says that Techniclone's technology should have a minimum value of 250 million. I don't think any analyst is allowing for sales of Oncolym right now. It appears that Oncolym would have to bite a Rituxan/Bexxar analyst before it received acknowledgement publicly. But they all know TCLN's potential and what Oncolym could add to their NHL arsenal.